Segniliparus rugosus infection, Australia

Emerging Infectious Diseases

Volumn 15, Issue 4, 2009, Pages 611-613

  Hansen, Tarrant ^a,f   Van Kerckhof, Janelle ^a   Jelfs, Peter ^b   Wainwright, Claire ^c,d   Ryan, Pat ^e   Coulter, Chris ^a  

^a Mycobacterium Reference Laboratory   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e TOWNSVILLE HOSPITAL   (Australia)

^f Pathology Queensland   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; ARYLSULFATASE; CEFOXITIN; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DNA; GATIFLOXACIN; IMIPENEM; LINEZOLID; MINOCYCLINE; MOXIFLOXACIN; RIFABUTIN; RNA 16S; SODIUM HYDROXIDE; TOBRAMYCIN;

ACHROMOBACTER XYLOSOXIDANS; ACID FAST BACTERIUM; ADOLESCENT; AUSTRALIA; BACTERIAL INFECTION; BACTERIAL STRAIN; BRONCHIECTASIS; BROTH DILUTION; CASE REPORT; CHRONIC DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DISK DIFFUSION; DNA SEQUENCE; DRUG RESPONSE; DRUG SENSITIVITY; ENZYME ACTIVITY; FEMALE; GENE MUTATION; HUMAN; HYBRIDIZATION; INFLUENZA VIRUS B; INOCULATION; LETTER; LIQUID CHROMATOGRAPHY; LUNG FUNCTION TEST; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM; NOCARDIA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RADIOMETRY; SEGNILIPARUS RUGOSUS; SPUTUM ANALYSIS; SPUTUM SMEAR; STENOTROPHOMONAS MALTOPHILIA; TREATMENT DURATION; VIRUS INFECTION;

ACTINOMYCETALES; ACTINOMYCETALES INFECTIONS; ADOLESCENT; COMMUNICABLE DISEASES, EMERGING; CYSTIC FIBROSIS; FEMALE; HUMANS; LUNG DISEASES; MICROBIAL SENSITIVITY TESTS; QUEENSLAND;

EID: 65349120141     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1504.081479     Document Type: Letter

References (8)

1. Butler WR, Sheils CA, Brown-Elliott BA, Charles NA, Colin AA, Gant MJ, et al. First isolations of Segniliparus rugosus from patients with cystic fibrosis. J Clin Microbiol. 2007;45:3449-52. DOI: 10.1128/JCM.00765-07
2. Wilton S, Cousins D. Detection and identification of multiple mycobacterial pathogens by DNA amplification in a single tube. PCR Methods Appl. 1992;1:269-73.
3. Richter E, Rusch-Gerdes S, Hillemann D. Evaluation of the genotype mycobacterium assay for identification of mycobacterial species from cultures. J Clin Microbiol. 2006;44:1769-75. DOI: 10.1128/JCM.44.5.1769-1775.2006
4. Butler WR, Floyd MM, Brown J, Toney SR, Daneshvar M, Cooksey RC, et al. Novel mycolic acid-containing bacteria in the family Segniliparaceae fam. nov., including the genus Segniliparus gen. nov., with descriptions of Segniliparus rotundus sp. nov., and Segniliparus rugosus sp. nov. Int J Syst Evol Microbiol. 2005;55:1615-24.
5. Brown-Elliott B, Beierle K, McGlasson M, Wallace R. MICs of non-tuberculous mycobacteria using the TREK Vizion system compared to manual readings. In: 18th European Congress of Clinical Microbiology and Infectious Diseases; Barcelona, Spain; 2008 April 19-22. Abstract R2410.
6. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial testing; sixteenth informational supplement. CLSI14 document M100-S16. Wayne (PA): The Institute; 2006.
7. National Committee on Clinical and Laboratory Standards (NCCLS). Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard. NCCLS document M24-A. Wayne (PA): The Committee; 2003.
8. Butler WR, Guthertz LS. Mycolic acid analysis by high performance liquid chromatography for identification of mycobacterium species. Clin Microbiol Rev. 2001;14:704-26. DOI: 10.1128/CMR.14.4.704-726.2001